Literature DB >> 17049798

Meropenem and imipenem activity against Pseudomonas aeruginosa isolates from the MYSTIC Program.

Philip J Turner1.   

Abstract

This article examines the activity of meropenem and imipenem against Pseudomonas aeruginosa isolates from the Meropenem Yearly Susceptibility Test Information Collection program between 1997 and 2005. In particular, it examines the activity of meropenem against imipenem-resistant strains and vice versa. Meropenem proved to be active against up to a 3rd of imipenem-resistant strains.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17049798     DOI： 10.1016/j.diagmicrobio.2006.07.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  5 in total

1.  Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.

Authors:  Marie-Laure Joly-Guillou; Marie Kempf; Jean-Didier Cavallo; Monique Chomarat; Luc Dubreuil; Jeanne Maugein; Claudette Muller-Serieys; Micheline Roussel-Delvallez
Journal:  BMC Infect Dis       Date:  2010-03-18       Impact factor: 3.090

Review 2.  Meropenem: a review of its use in the treatment of serious bacterial infections.

Authors:  Claudine M Baldwin; Katherine A Lyseng-Williamson; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

Review 4.  Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.

Authors:  Thomas G Slama
Journal:  Crit Care       Date:  2008-10-29       Impact factor: 9.097

5.  Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan.

Authors:  Manzoor Ahmad; Mukhtiar Hassan; Anwar Khalid; Imran Tariq; Muhammad Hassham Hassan Bin Asad; Abdul Samad; Qaisar Mahmood; Ghulam Murtaza
Journal:  Biomed Res Int       Date:  2016-06-05       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.